Search

Your search keyword '"Horisberger, B"' showing total 373 results
Start Over Author "Horisberger, B"

Refine your results

more »

more »

more »

more »
373 results on '"Horisberger, B"'

2. Socioeconomic Aspects of an Implantable Drug Delivery Device

Author

Horisberger, B., Sagmeister, M., Schmid, L., Herfarth, Ch., editor, Senn, H.-J., editor, Baum, M., editor, Diehl, V., editor, Grundmann, E., editor, Gutzwiller, F., editor, Hitzig, W., editor, Rajewsky, M. F., editor, Wannenmacher, M., editor, Senn, Hans-Jörg, editor, and Glaus, Agnes, editor

Published
1991
Full Text
View/download PDF

18. Kosten-Nutzen-Analyse

Author

Horisberger, B., Siewert, Jörg Rüdiger, editor, Blum, André Louis, editor, Goebell, Harald, editor, Hotz, Jürgen, editor, and Farthmann, Eduard Heinrich, editor

Published
1984
Full Text
View/download PDF

19. Was kostet ein Ulcus?

Author

Sonnenberg, A., Fritsch, A., Sierp, D., Bapst, L., Horisberger, B., Siewert, J. R., editor, Blum, A. L., editor, Blum, André Louis, editor, and Siewert, Jörg Rüdiger, editor

Published
1982
Full Text
View/download PDF

25. An economic analysis of ischaemic heart disease in Switzerland

Author

Sagmeister, M., Gessner, U., Oggier, W., Horisberger, B., Gutzwiller, F., Sagmeister, M., Gessner, U., Oggier, W., Horisberger, B., and Gutzwiller, F.

Abstract

Aims Direct and indirect costs of ischaemic heart disease were assessed in Switzerland, for the period 1988-1993, in order to evaluate the economic consequences of more intensive treatment of the disease and of the decreasing mortality from ischaemic heart disease in the working population. Methods and Results A societal perspective was taken for a prevalence-based assessment of the direct (total resources consumed by outpatients and inpatients) and indirect (due to morbidity, invalidity, and premature death, using the human capital approach) costs. The results showed the total costs were 21 million US dollars per 100 000 population in the year 1993 (47% direct, 53% indirect costs). The largest components were the direct costs of inpatient care and indirect costs due to premature death (each approximately 25% of the total). Trends showed a large increase in direct costs (+9% per year, constant dollars). Indirect costs stabilized or decreased slightly due to the reduction of work losses. Conclusions Today's medicine and preventive measures have proven effective for ischaemic heart disease, although such remedies have required increasingly large financial resources. However, society benefits because indirect costs decrease, although this gain does not compensate for all direct costs

Published
2017

26. Preface

Author

Brandt, A., Horisberger, B., von Wartburg, W. P., Abel-Smith, B., Brandt, A., editor, Horisberger, B., editor, von Wartburg, W. P., editor, and Abel-Smith, B., editor

Published
1980
Full Text
View/download PDF

29. Envoi

Author

Dinkel, R., primary and Horisberger, B., additional

Published
1988
Full Text
View/download PDF

32. Was kostet ein Ulcus?

Author

Sonnenberg, A., primary, Fritsch, A., additional, Sierp, D., additional, Bapst, L., additional, and Horisberger, B., additional

Published
1982
Full Text
View/download PDF

36. Neue Bücher

Author

Gass, R., Horisberger, B., Grandjean, E., Buchberger, J., Stephan, E., Biener, K., Gasser, M., and OMS

Published
1975
Full Text
View/download PDF

39. Envoi

Author

Dinkel, R., Horisberger, B., Davis, K., editor, van Eimeren, Wilhelm, editor, and Horisberger, Bruno, editor

Published
1988
Full Text
View/download PDF

42. Dem Rückenschmerz ein Gesicht geben

Author

Müller, U, primary, Mannion, AF, additional, Wieser, S, additional, Tamcan, O, additional, Ruckstuhl, A, additional, Elfering, A, additional, Eisenring, C, additional, Schmidhauser, S, additional, and Horisberger, B, additional

Published
2009
Full Text
View/download PDF

43. Donner un visage aux douleurs dorsales

Author

Müller, U, primary, Mannion, AF, additional, Wieser, S, additional, Tamcan, O, additional, Ruckstuhl, A, additional, Elfering, A, additional, Eisenring, C, additional, Schmidhauser, S, additional, and Horisberger, B, additional

Published
2009
Full Text
View/download PDF

49. Introduction

Author

Culyer, A.J., primary, Horisberger, B., additional, Jönsson, B., additional, and Rutten, F., additional

Published
1993
Full Text
View/download PDF

50. Cost of low back pain in Switzerland in 2005.

Author

Wieser S, Horisberger B, Schmidhauser S, Eisenring C, Brügger U, Ruckstuhl A, Dietrich J, Mannion AF, Elfering A, Tamcan O, Müller U, Wieser, Simon, Horisberger, Bruno, Schmidhauser, Sara, Eisenring, Claudia, Brügger, Urs, Ruckstuhl, Andreas, Dietrich, Jürg, Mannion, Anne F, and Elfering, Achim

Abstract

Low back pain (LBP) is the most prevalent health problem in Switzerland and a leading cause of reduced work performance and disability. This study estimated the total cost of LBP in Switzerland in 2005 from a societal perspective using a bottom-up prevalence-based cost-of-illness approach. The study considers more cost categories than are typically investigated and includes the costs associated with a multitude of LBP sufferers who are not under medical care. The findings are based on a questionnaire completed by a sample of 2,507 German-speaking respondents, of whom 1,253 suffered from LBP in the last 4 weeks; 346 of them were receiving medical treatment for their LBP. Direct costs of LBP were estimated at 2.6 billion and direct medical costs at 6.1% of the total healthcare expenditure in Switzerland. Productivity losses were estimated at 4.1 billion with the human capital approach and 2.2 billion with the friction cost approach. Presenteeism was the single most prominent cost category. The total economic burden of LBP to Swiss society was between 1.6 and 2.3% of GDP. [ABSTRACT FROM AUTHOR]

Published
2011
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results